Vitamin K2 MK-4: the Next Opportunity in US Supplements

Vitamin K2 awareness continues to grow in the US supplements market, but most products today rely almost exclusively on MK-7. This webinar explores why MK-4 represents the next strategic opportunity for brands, particularly within emerging positioning areas such as healthy aging, brain health, and longevity. During this session, we will review the scientific mechanisms and […]

Exclusives

Clause E Under the Microscope: FDA Reexamines the Boundaries of Dietary Ingredients

Agency asks whether innovation, from precision fermentation to probiotics, fits within DSHEA’s definition of ‘dietary substance.’

Exclusives

FDA Weighs Updates to Supplement Ingredient Framework as Innovation Accelerates

At a March 27 public meeting, FDA gathered industry input on the scope of dietary supplement ingredients, production technologies, and regulatory considerations.

Videos

Inside Cymbiotika’s Growth: Women-Led Innovation, Science, Transparency, and Retail Expansion

Co-founders Durana and Shahab Elmi emphasized clinical validation, authenticity, and women-centered product development in this interview at Natural Products Expo West.

Features

Protein at a Crossroads: Mass Adoption Meets Market Saturation

Protein has evolved beyond sports nutrition as demand grows for better-tasting, cleaner-label products that align with the needs and lifestyles of consumers everywhere.